NPM1 mutations define a specific subgroup of MDS and...

Blood Advances 2019 / 03 Vol. 3; Iss. 6

NPM1 mutations define a specific subgroup of MDS and MDS/MPN patients with favorable outcomes with intensive chemotherapy

Montalban-Bravo, Guillermo, Kanagal-Shamanna, Rashmi, Sasaki, Koji, Patel, Keyur, Ganan-Gomez, Irene, Jabbour, Elias, Kadia, Tapan, Ravandi, Farhad, DiNardo, Courtney, Borthakur, Gautham, Takahashi, K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
3
Journal:
Blood Advances
DOI:
10.1182/bloodadvances.2018026989
Date:
March, 2019
File:
PDF, 1.63 MB
2019
Conversion to is in progress
Conversion to is failed